Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)

    ... (OS) separately in the 2 arms at 1 year post-hematopoietic stem cell transplantation (HSCT). Status:  ... (MFI) > 1000 by solid phase immunoassay). Prior allogeneic stem cell transplant . Prior solid organ transplant. ...

    Clinical Trial last updated 05/22/2017 - 11:00am.

  2. Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.

    Journal Title:  Pediatr Transplant Primary Author:  ...

    Research Article last updated 05/14/2013 - 12:57pm.

  3. Optimizing management of myelodysplastic syndromes post-allogeneic transplantation

    ... December 1, 2011 Allogeneic hematopoietic stem cell transplantation is still the only potentially curative treatment for ...

    Research Article last updated 12/05/2011 - 10:23am.

  4. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.

    ... less durable. In most cases, cure is made more likely with allogeneic stem cell transplantation. These findings suggest that improved survival may ...

    Research Article last updated 02/04/2013 - 2:51pm.

  5. Patient selection for transplantation in the myelodysplastic syndromes.

    ... April 1, 2010 Allogeneic hematopoietic stem cell transplantation remains the only known curative procedure for the ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... are offering to treat the donor peripheral blood stem cells in the hope that it will make it less likely for the patient who ... Some patients on this study will receive an allogeneic stem cell transplant (AlloSCT) from a matched related donor ...

    Clinical Trial last updated 04/27/2016 - 8:55am.

  7. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... in children, adolescents and young adults receiving an allogeneic peripheral blood Status:  ... Hemoglobinopathies per protocol. Requirement for CD34+ stem cell selection for a second infusion of stem cells following an ...

    Clinical Trial last updated 06/13/2016 - 2:06pm.

  8. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children

    ... how well T cell depleted donor peripheral blood stem cell transplant works in preventing graft-versus-host disease in ... Patients who are considered appropriate candidates for allogeneic hematopoietic stem cell transplantation and have one of the ...

    Clinical Trial last updated 06/13/2016 - 2:29pm.

  9. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... This phase I trial studies the side effects of donor stem cell transplant in treating patients with high risk acute myeloid ... Patients must be medically ineligible for allogeneic stem cell transplant (alloSCTx) or not have a known fully ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  10. Selective Depletion of CD45RA+ Naive T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD

    ... myelogenous leukemia undergoing donor peripheral blood stem cell transplant . Giving chemotherapy and total-body ... Patients who are considered appropriate candidates for allogeneic hematopoietic stem cell transplantation and have one of the ...

    Clinical Trial last updated 06/06/2016 - 2:55pm.